Colgate-Palmolive Company (NYSE:CL) Stock Has Consensus Price Target of $98.00

Key Points

• Analysts maintain a moderately bullish view: Twenty brokerages give Colgate-Palmolive a consensus “Moderate Buy” rating, with 13 buys and seven holds. The average 12-month price target is $98.00, compared with the reported opening price of $94.10.
• Recent operating performance exceeded expectations: Colgate-Palmolive reported quarterly EPS of $0.99 versus the $0.95 consensus estimate, while revenue rose 4.9% year over year to $5.36 billion. Analysts expect full-year EPS of approximately $3.87.
• Risks and sentiment indicators are mixed: Insiders sold roughly $16.1 million of stock over the past three months, while investors face inflation, tariff and competitive pressures. The company continues to offer a quarterly dividend of $0.53 per share, yielding about 2.3% annually.

Colgate-Palmolive Company (NYSE:CL - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty brokerages that are currently covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $98.00.

A number of research firms have commented on CL. Piper Sandler reduced their target price on Colgate-Palmolive from $98.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, September 21st. Evercore boosted their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the company an "outperform" rating in a report on Thursday, October 8th. Barclays boosted their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 21st. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $103.00 to $104.00 and gave the company an "overweight" rating in a research report on Monday, October 19th. Finally, Weiss Ratings cut Colgate-Palmolive from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday, October 2nd.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 10,000 shares of the firm's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Noel Wallace sold 161,021 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total transaction of $14,801,050.32. Following the completion of the transaction, the chief executive officer directly owned 362,231 shares of the company's stock, valued at $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Company insiders own 0.43% of the company's stock.

Hedge Funds Weigh In On Colgate-Palmolive

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Virginia Estate & Retirement Planning Advisors Inc. lifted its holdings in shares of Colgate-Palmolive by 1,409.1% in the 3rd quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company's stock worth $28,000 after purchasing an additional 310 shares during the last quarter. Parvin Asset Management LLC acquired a new position in Colgate-Palmolive during the 2nd quarter valued at approximately $32,000. Park Place Capital Corp boosted its position in Colgate-Palmolive by 55.5% during the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after purchasing an additional 127 shares during the period. Cherry Tree Wealth Management LLC boosted its position in Colgate-Palmolive by 7,840.0% during the 2nd quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock valued at $36,000 after purchasing an additional 392 shares during the period. Finally, Montgomery Financial Services LLC bought a new position in Colgate-Palmolive during the 2nd quarter worth $36,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Analysts expect earnings growth, and Zacks says Colgate-Palmolive has a favorable combination of earnings estimates and historical earnings surprises that could support a quarterly beat. Colgate-Palmolive earnings expectations
• Positive Sentiment: Recent coverage has highlighted strong toothpaste performance, while Colgate-Palmolive India reported 12.2% revenue growth, 4.3% profit growth and modest gross-margin expansion. These results may offer some support for the broader brand portfolio, although the Indian subsidiary is not the same entity as the U.S.-listed parent. Colgate-Palmolive India quarterly results
• Neutral Sentiment: Options activity was elevated, with investors purchasing 4,443 put contracts—about 71% above typical volume—signaling increased hedging or bearish positioning ahead of the report, but not necessarily confirming a change in fundamentals.
• Neutral Sentiment: Institutional positioning was mixed in the latest quarter: 851 investors added shares while 853 reduced holdings. Analyst targets remain varied, with a reported median of $96, suggesting limited upside relative to recent trading levels.
• Negative Sentiment: Investors remain concerned about raw-material and packaging inflation, tariff effects, intense category competition and pressure on consumer spending. Management has also warned that volatile market conditions could persist through the rest of 2026. Colgate-Palmolive defensive rally and earnings risks
• Negative Sentiment: Insiders have reported five open-market sales and no purchases over the past six months, including substantial sales by CEO Noel Wallace. While insider transactions can reflect personal financial decisions, the lack of buying may weigh on sentiment.

Colgate-Palmolive Price Performance

CL opened at $94.10 on Friday. The company has a market capitalization of $75.02 billion, a P/E ratio of 37.34, a PEG ratio of 4.71 and a beta of 0.33. The company has a 50-day moving average of $89.26 and a 200-day moving average of $89.35. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. Colgate-Palmolive has a 1-year low of $74.54 and a 1-year high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. The business had revenue of $5.36 billion for the quarter, compared to analysts' expectations of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company's quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.92 earnings per share. Equities analysts expect that Colgate-Palmolive will post 3.87 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive's dividend payout ratio is 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.